Company Overview
Snapshot
Founded in September 2010, CureSound operates with 1–10 employees. The company has raised $600,000 across one funding round from one investor. In November 2017, the company's BRH-A2 device received FDA clearance to treat serious wounds using electric fields and ultrasound.
Business overview
CureSound specializes in noninvasive medical devices, developing the BRH-A wound-healing series. Its core product, the BRH-A2, is a noninvasive, FDA-cleared portable device that utilizes therapeutic ultrasound and electrostimulation to heal chronic ulcers, reduce lesion size, alleviate wound pain, and accelerate tissue regrowth. The company serves markets including healthcare providers, doctors, and clinics, focusing on patients with chronic conditions, seniors, and individuals seeking pain relief, operating within the Health Tech & Life Sciences sector.
Strategic signal
In November 2017, CureSound's BRH-A2 device received FDA clearance for treating serious wounds with electric fields and ultrasound. This regulatory approval validates the company's technology and expands its market access, signaling to investors a significant step towards commercialization and broader adoption in the medical device industry.
Log in to access full profile ›Company Intelligence Q&A
- What is CureSound's primary focus?
- CureSound specializes in noninvasive medical devices, particularly for wound healing, and is the developer of the BRH-A series.
- When was CureSound founded?
- CureSound was founded in September 2010.
- What is the BRH-A2 device?
- The BRH-A2 is a noninvasive, FDA-cleared portable device designed to heal chronic ulcers, reduce lesion size, lessen wound pain, and accelerate tissue regrowth through therapeutic ultrasound and electrostimulation.
- Has CureSound received any patents for its technology?
- In November 2016, CureSound received patents in both the USA and China for its innovative wound healing therapy.
- What was a significant regulatory milestone for CureSound?
- In November 2017, the FDA cleared CureSound's BRH-A2 device to treat serious wounds using electric fields and ultrasound.